Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Henshall

Showing results (31-40 of 259) with videos related to

Pageof 26
Sort By:
Oncotarget|June 15, 2017
Targeting the proteasome in epilepsyTobias Engel, Jose J Lucas, David C Henshall
Neurobiology of Disease|November 12, 2020
Epigenetic principles underlying epileptogenesis and epilepsy syndromesKaren Conboy, David C Henshall, Gary P Brennan
Epilepsy & Behavior : E&B|August 21, 2015
Comparison of short-term effects of midazolam and lorazepam in the intra-amygdala kainic acid model of status epilepticus in miceMairead Diviney, James P Reynolds, David C Henshall
Journal of Neurochemistry|September 29, 1999
Relationship between seizure-induced transcription of the DNA damage-inducible gene GADD45, DNA fragmentation, and neuronal death in focally evoked limbic epilepsyD C Henshall, J Sinclair, R P Simon
Journal of Neurochemistry|February 29, 2000
Involvement of caspase-3-like protease in the mechanism of cell death following focally evoked limbic seizuresD C Henshall, J Chen, R P Simon
European Journal of Pharmacology|February 5, 1999
Parallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemiaK Kawaguchi, D C Henshall, R P Simon
Frontiers in Cellular Neuroscience|June 7, 2021
Regulatory Mechanisms of the RNA Modification m<sup>6</sup>A and Significance in Brain Function in Health and DiseaseJustine Mathoux, David C Henshall, Gary P Brennan
Ebiomedicine|July 14, 2019
Targeting microRNA-134 for seizure control and disease modification in epilepsyGareth Morris, Cristina R Reschke, David C Henshall
Epilepsy & Behavior : E&B|June 8, 2019
MicroRNAs as biomarkers and treatment targets in status epilepticusElizabeth Brindley, Thomas D M Hill, David C Henshall
Neuropharmacology|November 10, 2015
ATPergic signalling during seizures and epilepsyTobias Engel, Mariana Alves, Caroline Sheedy, et al.
Pageof 26

Showing results (31-40 of 259) with videos related to

Sort By:
Pageof 26
Oncotarget|June 15, 2017
Targeting the proteasome in epilepsyTobias Engel, Jose J Lucas, David C Henshall
Neurobiology of Disease|November 12, 2020
Epigenetic principles underlying epileptogenesis and epilepsy syndromesKaren Conboy, David C Henshall, Gary P Brennan
Epilepsy & Behavior : E&B|August 21, 2015
Comparison of short-term effects of midazolam and lorazepam in the intra-amygdala kainic acid model of status epilepticus in miceMairead Diviney, James P Reynolds, David C Henshall
Journal of Neurochemistry|September 29, 1999
Relationship between seizure-induced transcription of the DNA damage-inducible gene GADD45, DNA fragmentation, and neuronal death in focally evoked limbic epilepsyD C Henshall, J Sinclair, R P Simon
Journal of Neurochemistry|February 29, 2000
Involvement of caspase-3-like protease in the mechanism of cell death following focally evoked limbic seizuresD C Henshall, J Chen, R P Simon
European Journal of Pharmacology|February 5, 1999
Parallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemiaK Kawaguchi, D C Henshall, R P Simon
Frontiers in Cellular Neuroscience|June 7, 2021
Regulatory Mechanisms of the RNA Modification m<sup>6</sup>A and Significance in Brain Function in Health and DiseaseJustine Mathoux, David C Henshall, Gary P Brennan
Ebiomedicine|July 14, 2019
Targeting microRNA-134 for seizure control and disease modification in epilepsyGareth Morris, Cristina R Reschke, David C Henshall
Epilepsy & Behavior : E&B|June 8, 2019
MicroRNAs as biomarkers and treatment targets in status epilepticusElizabeth Brindley, Thomas D M Hill, David C Henshall
Neuropharmacology|November 10, 2015
ATPergic signalling during seizures and epilepsyTobias Engel, Mariana Alves, Caroline Sheedy, et al.
Pageof 26